CMPX vs FOXA · $367.4M cap vs P/E 14, $24.50B cap
Compass Therapeutics Inc. (CMPX) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
CMPX does not have a complete income-statement cache yet.
FOXA does not have a complete income-statement cache yet.
CMPX currently screens at market cap $367.4M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the CMPX and FOXA stock pages for the full models.
Not investment advice.